Drug price control order
The task force recommendations
on drug pricing have been under the scrutiny of the
industry, while a new drug policy may be welcome,
industry specialists are more intereseted in the finer
aspect of the policy.The new Drug Pricing Control
Order (DPCO) is all set to replace the present order.
It is designed by taking into account, the recommendations
of the task force for pharma pricing and the Sandhu
Committee. The pharma task force, which was headed
by Pronab Sen, Principal Advisor of the Planning Commission,
has sparked off a series of discussions on what would
be beneficial to the industry as well as the consumers.
Following are some of the recommendations proposed
by the pharma task force for the new DPCO.
September 30, 2005